OliviaKathrynGiddingsMD

Physician

Dr. Giddings is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
130 Mason Farm Rd
CB 7020
Chapel Hill, NC 27759
Phone+1 919-966-1055

Fax+1 216-844-5916

University of North Carolina HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 2012 - 2015
Vanderbilt University Medical CenterResidency, Internal Medicine/Pediatrics, 2008 - 2012
Saint Louis University School of MedicineClass of 2008

S-Nitrosylation Therapy of COVID-19 Start of enrollment: 2021 Aug 05
Active, not recruiting
Early Phase 1

PubMed

3 citations
Antigen stasis and airway nitrosative stress in human primary ciliary dyskinesia.
Benjamin Gaston, Laura A Smith, Michael D Davis, Jessica Saunders, Ivana Daniels
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2024-04-01
25 citations
Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study.
James Welker, Juan D Pulido, Andrew T Catanzaro, Carlos D Malvestutto, Zihai Li
The Lancet. Infectious Diseases. 2022-05-01
3 citations
Airway Thiol-NO Adducts as Determinants of Exhaled NO.
Megan Pophal, Zachary W. Grimmett, Clara Chu, Seunghee Margevicius, Thomas Raffay
Antioxidants. 2021-09-26

Athersys Announces Commencement of Patient Enrollment in the MACOVIA Study, a Pivotal Phase 2/3 Trial Evaluating MultiStem® Cell Therapy for COVID-19 Induced ARDSMay 5th, 2020